| Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure. | |
| | |
MedLine Citation:
|
PMID: 19723834 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Age and increasing systolic blood pressure (BP) are associated with vascular endothelial dysfunction, but the factors involved are incompletely understood. We tested the hypothesis that vascular endothelial function is related to dietary sodium intake among middle-aged and older adults (MA and O) with elevated systolic BP. METHODS: Data were analyzed on 25 otherwise healthy adults aged 48-73 years with high normal systolic BP or stage I systolic hypertension (130-159 mmHg). Self-reported sodium intake was <100 mmol/d in 12 (7 M) subjects (low sodium, 73+/-6 mmol/d) and between 100 and 200 mmol/d in 13 (9 M) subjects (normal sodium, 144+/-6 mmol/d). RESULTS: Groups did not differ in other dietary factors, age, body weight and composition, BP, metabolic risk factors, physical activity and maximal aerobic capacity. Plasma concentrations of norepinephrine, endothelin-1, oxidized low-density lipoproteins (LDL), antioxidant status and inflammatory markers did not differ between groups. Brachial artery flow-mediated dilation (FMD) was 42% (mm Delta) to 52% (% Delta) higher in the low versus normal sodium group (p < 0.05). In all subjects, brachial artery FMD was inversely related to dietary sodium intake (FMD mm Delta r =-0.40, p < 0.05; %Delta r =-0.53, p < 0.01). Brachial artery FMD was not related to any other variable. In contrast, endothelium-independent dilation did not differ between groups (p >or= 0.24) and was not related to sodium intake in the overall group (p >or= 0.29). CONCLUSIONS: Low sodium intake is associated with enhanced brachial artery FMD in MA and O with elevated systolic BP. These results suggest that dietary sodium restriction may be an effective intervention for improving vascular endothelial function in this high-risk group. |
| | |
Authors:
|
Kristen L Jablonski; Phillip E Gates; Gary L Pierce; Douglas R Seals |
Related Documents
:
|
1330364 - The epidemiology of diet and blood pressure. 750154 - Saline-induced natriuresis in the dog without prior exposure of the kidney to the physi... 2115624 - Interrelations of blood pressure, glomerular filtration rate, protein clearances and so... 192514 - Further unravelling of the causes of acth-induced hypertension in the sheep. 11060134 - Action of polysaccharides of similar average mass but differing molecular volume and ch... 3158674 - Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2009-09-01 |
Journal Detail:
|
Title: Therapeutic advances in cardiovascular disease Volume: 3 ISSN: 1753-9447 ISO Abbreviation: Ther Adv Cardiovasc Dis Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: 2009-11-24 Revised Date: 2013-03-14 |
Medline Journal Info:
|
Nlm Unique ID: 101316343 Medline TA: Ther Adv Cardiovasc Dis Country: England |
Other Details:
|
Languages: eng Pagination: 347-56 Citation Subset: IM |
Affiliation:
|
Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA. Kristen.Jablonski@colorado.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Age Factors Aged Biological Markers / blood Blood Pressure* Brachial Artery / physiopathology* Diet Records Diet, Sodium-Restricted* Endothelium, Vascular / physiopathology* Female Humans Hypertension / blood, diet therapy*, etiology, physiopathology Male Middle Aged Regional Blood Flow Severity of Illness Index Sodium Chloride, Dietary / adverse effects* Vasodilation* |
| Grant Support | |
ID/Acronym/Agency:
|
AG000279/AG/NIA NIH HHS; AG006537/AG/NIA NIH HHS; AG013038/AG/NIA NIH HHS; AG022241/AG/NIA NIH HHS; AG033994/AG/NIA NIH HHS; F31 AG033994/AG/NIA NIH HHS; RR00051/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Sodium Chloride, Dietary |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently...
Next Document: Elafin (SKALP/Trappin-2/proteinase inhibitor-3) Is Produced by the Cervix in Pregnancy and Cervicova...